Search clinical trials for: Elotuzumab, pomalidomide, dexamethasone
Total 3792 results
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Natalie CallendarBristol-Myers SquibbWithdrawn
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
AbbottBristol-Myers SquibbTerminated
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbAbbVie; CelgeneCompletedMultiple MyelomaUnited States, Germany, Italy, Greece, Netherlands, Australia, Spain, Poland, Canada, France, Japan
-
AbbVie (prior sponsor, Abbott)Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbNo longer available
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
AbbVieNot yet recruiting
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
OncotherapeuticsTerminated
-
Massachusetts General HospitalBristol-Myers Squibb; Celgene; Multiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
Peking University People's HospitalQingdao Municipal HospitalRecruiting
-
Seagen Inc.Terminated
-
National University Hospital, SingaporeCelgeneUnknownMultiple Myeloma | Relapse After Use of Lenalidomide and BortezomibSingapore
-
IRCCS Policlinico S. MatteoCompletedPrimary Amyloidosis of Light Chain TypeItaly
-
PETHEMA FoundationBristol-Myers Squibb; Celgene; Adknoma Health Research, S.L.TerminatedMultiple MyelomaSpain
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Israel, Spain, Australia, Brazil, United Kingdom, Poland, Taiwan, Singapore, France, Canada, Italy
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
Bristol-Myers SquibbAbbVieCompleted
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbCompleted
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, France, Poland, Australia, Netherlands, United Kingdom, India
-
Steven P. Treon, MD, PhDCelgene CorporationTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Bristol-Myers SquibbAbbVieCompleted
-
University of Heidelberg Medical CenterCompleted
-
Calithera Biosciences, IncCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma (NHL) | Waldenstrom's Macroglobulinemia (WM) | Other B-cell NHL Subtypes, Including WM | T-cell NHLUnited States
-
PETHEMA FoundationCelgene Corporation; Array BioPharmaCompleted
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Children's Hospital Medical Center, CincinnatiBill and Melinda Gates Foundation; Syngene InternationalCompleted
-
Seoul National University Bundang HospitalCompletedEvaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or BetamethasoneBack Pain | Neck PainKorea, Republic of
-
Facet BiotechCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaCanada, United States, Israel, Czechia, Switzerland, Greece, Denmark, Portugal, Italy, Germany, Austria, Norway, Puerto Rico, Spain, Sweden, Turkey
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid Tumors
-
Merck Sharp & Dohme LLCAriad PharmaceuticalsCompleted
-
Ascentage Pharma Group Inc.RecruitingMultiple Myeloma | AmyloidosisUnited States
-
Ahmadu Bello University Teaching HospitalCompletedNeonatal Respiratory Distress SyndromeNigeria
-
University of OklahomaStony Brook UniversityCompletedIntraventricular Hemorrhage | Respiratory Distress Syndrome | Neonatal MortalityUnited States